Dr. Terry Fry ACCELERATING CANCER RESEARCH Sharing resources, talent, and expertise expedites the pace of discovery, pushes development, and delivers life-saving products to patients in need much more quickly. For many of thesereasons,Children’sHospitalColoradoandtheUniversity of Colorado School of Medicine attracted one of the coun- try’s leading cancer researchers, Dr. Terry J. Fry, co-director of the Human Immunology and Immunotherapy Initiative and director of Cancer Immunotherapy at the University of Colorado School of Medicine. Dr. Fry was excited to join the team, saying, “one reason I came to Colorado was that I would be collaborating with outstanding scientists doing good science in this field, and not just trials. We have strong groups studying immunology at large academic institutions in Colorado. Biotech spinoffs from the university have experience in immunology and immunotherapy, and plenty of great biotech talent graduates every year. These assets make Colorado an ideal place to partner with others to solve immunologic challenges, such as devel- oping CAR-T cell therapies to fight cancer.” 7 2019-2020 / / BIOSCIENCECOLORADO